Heather L Huelster1, Aaron A Laviana1, Daniel D Joyce1, Li-Ching Huang2, Zhiguo Zhao2, Tatsuki Koyama2, Karen E Hoffman3, Ralph Conwill4, Michael Goodman5, Ann S Hamilton6, Xiao-Cheng Wu7, Lisa E Paddock8, Antoinette Stroup8, Matthew Cooperberg9, Mia Hashibe10, Brock B O'Neil11, Sherrie H Kaplan12, Sheldon Greenfield12, David F Penson1, Daniel A Barocas13. 1. Department of Urology, Vanderbilt University Medical Center, Nashville, TN. 2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. 3. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. 4. Office of Patient and Community Education, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Nashville, TN. 5. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. 6. Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CA. 7. Department of Epidemiology, Louisiana State University New Orleans School of Public Health, New Orleans, LA. 8. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton, NJ. 9. Department of Urology, University of California, San Francisco, CA. 10. Department of Family and Preventative Medicine, University of Utah School of Medicine, Salt Lake City, UT. 11. Department of Urology, University of Utah Health, Salt Lake City, UT. 12. Department of Medicine, University of California Irvine, Irvine, CA. 13. Department of Urology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: dan.barocas@vumc.org.
Abstract
INTRODUCTION AND OBJECTIVE: The timing of radiotherapy (RT) after prostatectomy is controversial, and its effect on sexual, urinary, and bowel function is unknown. This study seeks to compare patient-reported functional outcomes after radical prostatectomy (RP) and postprostatectomy radiation as well as elucidate the timing of radiation to allow optimal recovery of function. METHODS: The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study is a prospective, population-based, observational study of men with localized prostate cancer. Patient-reported sexual, urinary, and bowel functional outcomes were measured using the 26-item Expanded Prostate Index Composite at baseline and at 6, 12, 36, and 60 months after enrollment. Functional outcomes were compared among men undergoing RP alone, post-RP adjuvant radiation (RP + aRT), and post-RP salvage radiation (RP + sRT) using multivariable models controlling for baseline clinical, demographic, and functional characteristics. RESULTS: Among 1,482 CEASAR participants initially treated with RP for clinically localized prostate cancer, 11.5% (N = 170) received adjuvant (aRT, N = 57) or salvage (sRT, N = 113) radiation. Men who received post-RP RT had worse scores in all domains (sexual function [-9.0, 95% confidence interval {-14.5, -3.6}, P < 0.001], incontinence [-8.8, {-14.0, -3.6}, P < 0.001], irritative voiding [-5.9, {-9.0, -2.8}, P < 0.001], bowel irritative [-3.5, {-5.8, -1.2}, P = 0.002], and hormonal function [-4.5, {-7.2, -1.7}, P = 0.001]) compared to RP alone at 5 years of follow-up. Compared to men treated with RP alone in an adjusted linear model, sRT was associated with significantly worse scores in all functional domains. aRT was associated with significantly worse incontinence, urinary irritation, and hormonal function domain scores compared to RP alone at 5 years of follow-up. On multivariable modeling, RT administered approximately 24 months after RP was associated with the smallest decline in sexual domain score, with an adjusted mean decrease of 8.85 points (95% confidence interval [-19.8, 2.1]) from post-RP, pre-RT baseline. CONCLUSIONS: In men with localized prostate cancer, post-RP RT was associated with significantly worse sexual, urinary, and bowel function domain scores at 5 years compared to RP alone. Radiation delayed for approximately 24 months after RP may be optimal for preserving erectile function compared to radiation administered closer to the time of RP.
INTRODUCTION AND OBJECTIVE: The timing of radiotherapy (RT) after prostatectomy is controversial, and its effect on sexual, urinary, and bowel function is unknown. This study seeks to compare patient-reported functional outcomes after radical prostatectomy (RP) and postprostatectomy radiation as well as elucidate the timing of radiation to allow optimal recovery of function. METHODS: The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study is a prospective, population-based, observational study of men with localized prostate cancer. Patient-reported sexual, urinary, and bowel functional outcomes were measured using the 26-item Expanded Prostate Index Composite at baseline and at 6, 12, 36, and 60 months after enrollment. Functional outcomes were compared among men undergoing RP alone, post-RP adjuvant radiation (RP + aRT), and post-RP salvage radiation (RP + sRT) using multivariable models controlling for baseline clinical, demographic, and functional characteristics. RESULTS: Among 1,482 CEASAR participants initially treated with RP for clinically localized prostate cancer, 11.5% (N = 170) received adjuvant (aRT, N = 57) or salvage (sRT, N = 113) radiation. Men who received post-RP RT had worse scores in all domains (sexual function [-9.0, 95% confidence interval {-14.5, -3.6}, P < 0.001], incontinence [-8.8, {-14.0, -3.6}, P < 0.001], irritative voiding [-5.9, {-9.0, -2.8}, P < 0.001], bowel irritative [-3.5, {-5.8, -1.2}, P = 0.002], and hormonal function [-4.5, {-7.2, -1.7}, P = 0.001]) compared to RP alone at 5 years of follow-up. Compared to men treated with RP alone in an adjusted linear model, sRT was associated with significantly worse scores in all functional domains. aRT was associated with significantly worse incontinence, urinary irritation, and hormonal function domain scores compared to RP alone at 5 years of follow-up. On multivariable modeling, RT administered approximately 24 months after RP was associated with the smallest decline in sexual domain score, with an adjusted mean decrease of 8.85 points (95% confidence interval [-19.8, 2.1]) from post-RP, pre-RT baseline. CONCLUSIONS: In men with localized prostate cancer, post-RP RT was associated with significantly worse sexual, urinary, and bowel function domain scores at 5 years compared to RP alone. Radiation delayed for approximately 24 months after RP may be optimal for preserving erectile function compared to radiation administered closer to the time of RP.
Authors: Ashwin S Balakrishnan; Shoujun Zhao; Janet E Cowan; Jeanette M Broering; Matthew R Cooperberg; Peter R Carroll Journal: Urology Date: 2019-05-28 Impact factor: 2.649
Authors: Nicola Fossati; R Jeffrey Karnes; Stephen A Boorjian; Marco Moschini; Alessandro Morlacco; Alberto Bossi; Thomas Seisen; Cesare Cozzarini; Claudio Fiorino; Barbara Noris Chiorda; Giorgio Gandaglia; Paolo Dell'Oglio; Steven Joniau; Lorenzo Tosco; Shahrokh Shariat; Gregor Goldner; Wolfgang Hinkelbein; Detlef Bartkowiak; Karin Haustermans; Bertrand Tombal; Francesco Montorsi; Hein Van Poppel; Thomas Wiegel; Alberto Briganti Journal: Eur Urol Date: 2016-07-30 Impact factor: 20.096
Authors: Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino Journal: J Urol Date: 2002-02 Impact factor: 7.450
Authors: Mark S Litwin; Sheldon Greenfield; Eric P Elkin; Deborah P Lubeck; Jeanette M Broering; Sherrie H Kaplan Journal: Cancer Date: 2007-05-01 Impact factor: 6.860
Authors: J N Nyarangi-Dix; J Steimer; T Bruckner; H Jakobi; S A Koerber; B Hadaschik; J Debus; M Hohenfellner Journal: World J Urol Date: 2017-08-31 Impact factor: 4.226
Authors: Greetta Hackman; Kimmo Taari; Teuvo L Tammela; Mika Matikainen; Mauri Kouri; Timo Joensuu; Tiina Luukkaala; Arto Salonen; Taina Isotalo; Anssi Pétas; Niilo Hendolin; Peter J Boström; Sirpa Aaltomaa; Kari Lehtoranta; Pekka Hellström; Jarno Riikonen; Merja Korpela; Heikki Minn; Pirkko-Liisa Kellokumpu-Lehtinen; Eero Pukkala; Akseli Hemminki Journal: Eur Urol Date: 2019-07-30 Impact factor: 20.096
Authors: Daniel A Barocas; Vivien Chen; Matthew Cooperberg; Michael Goodman; John J Graff; Sheldon Greenfield; Ann Hamilton; Karen Hoffman; Sherrie Kaplan; Tatsuki Koyama; Alicia Morgans; Lisa E Paddock; Sharon Phillips; Matthew J Resnick; Antoinette Stroup; Xiao-Cheng Wu; David F Penson Journal: J Comp Eff Res Date: 2013-07 Impact factor: 1.744